Introduction
Most fungal infections of the cornea occur either in the setting of trauma or in association with preexisting corneal disease actively under treatment with antibiotics or corticosteroids. When ocular trauma occurs, it often involves some type of vegetable matter. Antibiotics are known to change the indigenous ocular flora in a way that allows mycotic organisms to more easily flourish in the absence of the normal inhibitory action of bacteria. Finally, corticosteroids are well known to suppress immune defenses, thus increasing susceptibility to infections. Rhodotorula is a yeast organism that is common in the environment but rarely the cause of human disease. A search of the literature reveals that Rhodotorula can be considered an emerging pathogen with an increasing number and variety of disease processes having been attributed to this organism over the last few decades [1] . Although Rhodotorula is of low virulence, it is an opportunistic pathogen that can affect both immunosuppressed, as well as immunologically competent humans under the appropriate circumstances [1] . Fungemia is the most common manifestation by far, with over 100 cases documented in the medical literature. Rhodotorula has also been shown to be the causative agent in cases of endocarditis, peritonitis, meningitis as well as infections of the skin, prosthetic joints and the eye. Of all these other areas, ocular infections are the most common site of Rhodotorula disease, being second only to sepsis. At present, there are 15 cases of eye infections in the medical literature [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . We believe this is the first case report of Rhodotorula mucilaginosa keratitis in the US. In addition, this is the first demonstration of in vivo confocal imaging of R. mucilaginosa.
Case Report
A 22-year-old gentleman presented to our clinic reporting that he was struck in his left eye with a tree branch two days previously. Immediately after the injury he vigorously flushed his eye out with tap water, but the next day he continued to have eye pain and poor vision and reported to the local urgent care facility. He was diagnosed with a corneal abrasion, started on sulfacetamide drops every two hours, and advised to follow-up with an ophthalmologist. He was seen in our clinic for a follow-up evaluation the next day. Upon examination he was found to have a best-corrected visual acuity (BCVA) of 20/200 and a 2 × 3 mm epithelial defect just below the corneal apex. The defect was noteworthy because it was associated with a very prominent infiltrate of the anterior corneal stroma. Cultures of the cornea were performed for bacterial, viral and fungal organisms, and the patient was started on moxifloxacin eye drops every hour with directions to follow-up in 24 hours.
The next day there was no significant change in the patient's condition. He was seen again 48 hours later and the epithelial defect was almost healed except for the appearance of moderate punctate epithelial erosions in the distribution of the original abrasion as well as the dense stromal cellular infiltrate. Although the BCVA had improved to 20/30, the stromal infiltrate persisted and involved the anterior one-third of the cornea. Cultures had become positive for germ tube-negative yeast ( fig. 1 ). There was no consolidation of the infiltrate, abscess formation or ulceration. Furthermore, the deep cornea remained uninvolved and there was no anterior chamber reaction. The patient was immediately started on voriconazole 1% drops every hour. Seventy-two hours later, eight days after the initial injury, the patient was examined again and his vision had improved to 20/20 (BCVA) and the epithelial defect had healed. Still, a cellular infiltrate remained in the anterior one-third of the corneal stroma, though it was concentrated more centrally with peripheral clearing ( fig. 2a, b) . The patient was sent for confocal microscopy. Confocal images ( fig. 3 ) revealed both round and dumbbell shaped structures suggestive of budding yeast forms as well as extensive branching structures resembling hyphae or pseudohyphae structures. Twelve days after the initial injury the patient was seen again and the infiltrate seemed to have improved and vision remained stable. By this visit the fungal culture was identified as R. mucilaginosa by DNA sequencing, and after a review of the literature suggested that amphotericin B would provide good coverage [1] , topical amphotericin B 0.15% was added to his treatment schedule. One week later the patient returned and the infiltrate seemed to be nearly resolved, but a residual haze of the anterior corneal stroma persisted. One month after the initial injury only a faint stromal haze remained. Repeat confocal microscopy at this time ( fig.  4 ) demonstrated that the inflammatory process had impressively resolved leaving what appeared to be residual fragments of the previously seen branching structures that had lost their tubular architecture. The patient was continued on amphotericin and voriconazole for a total course of three months at which time medications were discontinued with apparent full resolution of the infectious process. A full three months of treatment was administered because it is known that fungal infections require prolonged therapy [18] . The patient has continued to do well.
Discussion
We present the case of a young and healthy male college student with rapidly progressive corneal inflammation after minor vegetable matter trauma. He presented early before any deep stromal invasion or stromal ulceration could occur. Confocal findings were consistent with fungal keratitis and he was started early on topical voriconazole. When cultures were positive for R. mucilaginosa, amphotericin B was added to his topical antifungal regimen. In vitro susceptibility testing was performed showing low minimum inhibitory concentration (MIC) with amphotericin B, but relatively high MIC with voriconazole. The patient responded well clinically, and at three months after presentation he was asymptomatic with 20/20 corrected visual acuity and a clear cornea.
Review of the Literature
The exact incidence of fungal keratitis in the US is not known [19] . Similarly, a PubMed search could not establish the proportion of infectious keratitis that is fungal within the US. In Asia, the proportion of culture-proven fungal keratitis has been reported to be over 50% in some instances, thereby exceeding the rate of bacterial keratitis [19] . In the US and other temperate climates, mycotic keratitis is fairly unusual but is still commonly seen in tertiary referral centers like our own, and the medical literature shows that it accounts for significant morbidity across the globe. A combination of factors may contribute to this, including the trend for most ophthalmologists to treat empirically for bacterial pathogens, delayed identification of the organism, and poor availability and only fair efficacy of ophthalmic antifungal medications.
The genus Rhodotorula includes eight species, of which R. mucilaginosa, R. glutinis and R. minutae are known to cause human disease [1] . This yeast is common in the environment but very uncommon in the normal ocular flora [2] . It produces unique red-orange colonies when grown in culture and has a strong affinity for plastic [1] . This explains its predilection for causing sepsis in patients that have chronic indwelling catheters. Ocular Rhodotorula infections have been reported in the form of keratitis [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] , scleritis [12] , dacryosystitis [6] and endophthalmitis [13] [14] [15] [16] . The first reported case of Rhodotorula keratitis was by Wawer in 1965 [3] . Since then, nine additional reports of keratitis have been published (table 1) . Two of those reports are apparently the same case [2, 20] , giving a total of 9 cases of Rhodotorula keratitis in the published literature to date. Although the affected individuals were generally healthy, most of them had associated trauma (six cases) and three had prior corneal surgery. Seven patients required some form of surgical intervention to achieve resolution, four of them having penetrating keratoplasties, two needing repeat penetrating keratoplasty, and one requiring removal of a prior lamellar graft.
Confocal microscopy has shown itself to be a useful adjunct in the diagnosis of these infections. Cultures are positive only about 60% of the time and may take weeks to become positive. In the present case we used confocal microscopy to confirm the results of cultures that had already been confirmed as R. mucilaginosa by DNA sequencing. Confocal microscopy revealed that both round and dumbbell shaped structures of the correct size and morphology were present ( fig. 4 ). These were suggestive of budding yeast forms as well as tubular branching structures resembling hyphae or pseudohyphae. Rhodotorula species do not normally form branching structures when they grow on laboratory culture media. However, under certain conditions, such as in a biofilm, this organism can form extensive pseudomycelium [17] . Furthermore, a case of a corneal button removed for Rhodotorula infection in Italy in 1992 demonstrated that pseudomycelium, although not seen in vitro, is a morphology that can manifest in corneal infections [4] . To our knowledge, Rhodotorula pseudomycelium seen in vivo has not been reported.
Of note, there are no established breakpoints to interpret susceptibility testing results for this yeast. In 2005, Gomez-Lopez et al. [21] performed in vitro antifungal susceptibility testing of 29 clinical Rhodotorula isolates (25 R. mucilaginosa and 4 R. glutinis). Their results showed that amphotericin B and flucytosine had the highest in vitro activity against Rhodotorula spp., and fluconazole had the lowest activity, with itraconazole, voriconazole, and ravuconazole showing intermediate activity. In addition, the authors reviewed nine reports (a total of 102 Rhodotorula organisms) and found similar results. Presently, none of the reported cases were isolated from ocular infection. Only two previous Rhodotorula case reports tested antifungal susceptibility. Rajmane et al. [10] found MICs for fluconazole and itraconazole were very high (MIC90 = 64 µg/ml) and amphotericin B showed the lowest MIC (MIC90 = 1 µg/ml). Saha et al. [11] found maximum sensitivity to voriconazole, intermediate activity to amphotericin B and natamycin, and resistance to itraconazole and fluconazole. The most recent large review from the European Society of Clinical Microbiology and Infectious Diseases [18] recommends that amphotericin B be the treatment of choice in Rhodotorula infections. In our keratitis case Rhodotorula had low MICs to both amphotericin B and flucytosine while showing relatively high MIC to voriconazole.
In summary we report the case of an unusual keratitis in a young healthy patient that we believe to be the first report of Rhodotorula keratitis in the US. Our patient responded to topical medical treatment with good results as opposed to cases in the literature that required surgery or had poor visual outcomes. This is the first reported case of R. mucilaginosa keratitis with in vivo confocal microscopy that demonstrates the organism in an unusual morphology that has not been seen before in vivo. 
